Vyome Holdings Inc stock is traded at $1.60, with a volume of 7,742. It is down -1.84% in the last 24 hours and down -22.33% over the past month. Vyome Holdings Inc is a clinical-stage specialty pharmaceutical company working to treat immune-inflammatory and rare diseases of unmet need with next-generation therapeutic solutions. Its product candidates are: VT-1953, a topical gel that is being developed to treat signs and symptoms of malignant fungating wounds in cancer; VT-1908, a repurposed immune modulator to treat steroid-sparing anterior uveitis; and VB1953, which is being developed to treat moderate to severe acne. Vyome has also commercialized two novel reformulated topical anti-fungal products based on the technology platform of Molecular Replacement Therapeutics (MRT) in India: a dandruff lotion and shampoo. It operates in two segments: pharmaceutical products, which generate the maximum revenue, and biotechnology.
Previous Close:
$1.63
Open:
$1.66
24h Volume:
7,742
Relative Volume:
0.50
Market Cap:
$11.23M
Revenue:
$1.34M
Net Income/Loss:
-$13.49M
P/E Ratio:
-
EPS:
-$12.41
Net Cash Flow:
-$3.07M
1W Performance:
-11.11%
1M Performance:
-22.33%
6M Performance:
-27.27%
1Y Performance:
-71.73%
1-Day Range:
$1.60$1.66
1-Week Range:
$1.60$1.91
52-Week Range:
$1.60$6.19
Vyome Holdings Inc Stock (HIND) Company Profile
Name
Vyome Holdings IncSector
HealthcareIndustry
BiotechnologyPhone
949-429-6680Address
1001 CALLE AMANECER, SAN CLEMENTE, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS